CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- S-3/A Offering Registration Statement
- 4 Grant or award Chief Executive Officer acquired 50,000 shares (grant or award)
- 4 Open-market sale SVP, General Counsel sold 25,734 shares at $0.90 ($23,271)
- 4 Open-market sale Director sold 25,000 shares at $0.97 ($24,150)
- 4 Open-market sale SVP, General Counsel sold 25,210 shares at an average $1.05 ($26,484)
- 4 Open-market sale Chief Financial Officer sold 29,122 shares at $1.05 ($30,596)
- 4 Open-market sale Chief Executive Officer sold 45,409 shares at $1.09 ($49,382)
- 4 Grant or award SVP, General Counsel acquired 136,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 8-K Event Executive or director change
- 4 Grant or award Chief Financial Officer acquired 238,000 shares (grant or award)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
Page 22 of 66 · 1,318 filings